Loading...
We would love for you to become a part of our community. Join our Discord to connect with us and other members!
- Ticker
- PBP.AU
- Price
- -
- Stock movement up
- +- (%)
- Company name
- Probiotec Ltd
- Exchange
- (AU ,
- Currency
- AUD )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 242.34M
- Ent value
- 372.62M
- Price/Sales
- 0.64
- Price/Book
- 2.74
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- 69.76%
- Trailing P/E
- 14.32
- Forward P/E
- 14.90
- PEG
- -
- EPS growth
- 18.33%
- 1 year return
- 12.88%
- 3 year return
- 11.84%
- 5 year return
- 13.89%
- 10 year return
- 20.94%
Last updated: 2024-12-17
DIVIDENDS
PBP.AU does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 14.32 |
| Price to OCF | 11.52 |
| Price to FCF | 25.20 |
| Price to EBITDA | 4.80 |
| EV to EBITDA | 7.38 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.64 |
| Price to Book | 2.74 |
| EV to Sales | 0.98 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 81.32M |
| EPS (TTM) | 0.20 |
| FCF per share (TTM) | 0.11 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 381.62M |
| Gross profit (TTM) | 105.68M |
| Operating income (TTM) | 34.30M |
| Net income (TTM) | 16.93M |
| EPS (TTM) | 0.20 |
| EPS (1y forward) | 0.20 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 27.69% |
| Operating margin (TTM) | 8.99% |
| Profit margin (TTM) | 4.44% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 12.84M |
| Net receivables | 34.73M |
| Total current assets | 72.62M |
| Goodwill | 0.00 |
| Intangible assets | 84.08M |
| Property, plant and equipment | 0.00 |
| Total assets | 231.44M |
| Accounts payable | 30.69M |
| Short/Current long term debt | 86.11M |
| Total current liabilities | 46.00M |
| Total liabilities | 143.11M |
| Shareholder's equity | 88.33M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 21.04M |
| Capital expenditures (TTM) | 11.42M |
| Free cash flow (TTM) | 9.62M |
| Dividends paid (TTM) | 6.71M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 19.16% |
| Return on Assets | 7.31% |
| Return on Invested Capital | 17.75% |
| Cash Return on Invested Capital | 10.09% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| PBP.AU | S&P500 | |
| Current price drop from All-time high | -1.65% | - |
| Highest price drop | -94.55% | -56.47% |
| Date of highest drop | 28 May 2015 | 9 Mar 2009 |
| Avg drop from high | -48.62% | -11.12% |
| Avg time to new high | 68 days | 12 days |
| Max time to new high | 3454 days | 1805 days |
COMPANY DETAILS
Marketcap
242.34M
Marketcap category
Small-cap
Description
Probiotec Limited engages in the development, manufacture, packing, distribution, and sale of prescription and over the counter pharmaceuticals, complementary medicines and consumer health products, and fast-moving consumer products in Australia and internationally. The company provides contract manufacturing services for solid dose tablets, capsules, and caplets; tablets coatings; blister packs, bottles, sachets, tubs, and tubes; liquids, creams, gels, lotions, ointments, and powders and powder blends. It is also involved in analytical and stability testing services; new product formulation and production trials, and ongoing research and development services; and packaging options for human and animal nutrition products, as well as manufactures and exports a range of nutraceuticals and functional ingredient raw materials. The company was incorporated in 1996 and is headquartered in Laverton North, Australia. As of June 18, 2024, Probiotec Limited operates as a subsidiary of PYFA Australia Pty Ltd.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found